|
SEPT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.558300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.504800E-03 |
| Normal-vs-Stage2 |
7.468100E-02 |
| Normal-vs-Stage3 |
8.199600E-01 |
| Normal-vs-Stage4 |
7.950200E-01 |
| Stage1-vs-Stage2 |
8.627800E-01 |
| Stage1-vs-Stage3 |
1.663000E-01 |
| Stage1-vs-Stage4 |
4.279600E-01 |
| Stage2-vs-Stage3 |
1.900230E-01 |
| Stage2-vs-Stage4 |
3.531800E-01 |
| Stage3-vs-Stage4 |
9.200000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.095900E-02 |
| Normal-vs-AfricanAmerican |
2.263500E-02 |
| Normal-vs-Asian |
2.148000E-01 |
| Caucasian-vs-AfricanAmerican |
4.661400E-01 |
| Caucasian-vs-Asian |
8.788000E-01 |
| AfricanAmerican-vs-Asian |
9.108000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.824320E-03 |
| Normal-vs-Female |
6.927400E-01 |
| Male-vs-Female |
5.144000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.028200E-02 |
| Normal-vs-Extreme_Weight |
1.700660E-03 |
| Normal-vs-Obese |
5.650600E-01 |
| Normal-vs-Extreme_Obese |
1.160360E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.808800E-01 |
| Normal_Weight-vs-Obese |
1.769840E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.186000E-01 |
| Extreme_Weight-vs-Obese |
4.828200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.851800E-01 |
| Obese-vs-Extreme_Obese |
3.418000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.039200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.150800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.158500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.499000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.846180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.276900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.814100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.300900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.073600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.811540E-02 |
| Normal-VS-Type2 PRCC |
7.280000E-03 |
| Normal-VS-KIRP CIMP |
5.858000E-02 |
| Normal-VS-Unclassified PRCC |
9.662200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.694400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.592300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.735700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.042000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.222100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.301700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.201500E-04 |
| Normal-vs-N1 |
3.148600E-01 |
| Normal-vs-N2 |
3.770800E-01 |
| N0-vs-N1 |
9.098200E-03 |
| N0-vs-N2 |
6.250300E-02 |
| N1-vs-N2 |
9.813400E-01 |
|
|
